Microdermics

About:

Unlocking continuous biochemical data for clinically relevant insights.

Website: http://www.microdermics.com/

Twitter/X: MicrodermicsInc

Top Investors: Angel Forum, K5 Ventures, Innovate BC, E-Fund, Shoreline Venture Management

Description:

Microdermics is a Vancouver-based medical device company built on research at the University of British Columbia revolutionizing the biopharmaceutical market for both patients and healthcare practitioners. As the only company with a low-cost, scalable, hollow, metal microneedle, Microdermics eliminates the danger of accidental needle sticks caused by hypodermic needles and addresses the global health impact related to needle phobia. Microdermics will leverage its proprietary and innovative delivery system across a spectrum of biopharmaceuticals, including a new market for biosimilars, providing biopharmaceutical companies with a means of differentiating themselves from their competitors as well as securing product lifecycle extensions.

Total Funding Amount:

$1.08M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2014-01-01

Contact Email:

info(AT)microdermics.com

Founders:

Boris Stoeber, Iman Mansoor, Sahan Ranamukhaarachchi

Number of Employees:

1-10

Last Funding Date:

2017-04-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai